These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3131632)

  • 1. Clinical applications of urokinase-treated material.
    Ohshiro T; Liu MC; Kambayashi J; Mori T
    Methods Enzymol; 1988; 137():529-45. PubMed ID: 3131632
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical modification of enzyme molecules to improve their characteristics.
    Cao SG; Zhao QY; Ding ZT; Ma L; Yu T; Wang JH; Feng Y; Cheng YH
    Ann N Y Acad Sci; 1990; 613():460-7. PubMed ID: 2075996
    [No Abstract]   [Full Text] [Related]  

  • 3. Immobilized enzymes for thrombolytic therapy.
    Torchilin VP; Maksimenko AV; Mazaev AV
    Methods Enzymol; 1988; 137():552-66. PubMed ID: 2967420
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of immobilized enzymes for biomaterials used in surgery.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    Methods Enzymol; 1988; 137():545-51. PubMed ID: 3374358
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen-immobilized urokinase demonstrates increased thrombolytic activity in animal experiments.
    Maksimenko AV; Samarenko MB; Petrov AD; Tischenko EG; Ruda MYa ; Torchilin VP
    Ann N Y Acad Sci; 1990; 613():479-82. PubMed ID: 1706154
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the properties of immobilized urokinase: effects of pH and temperature.
    Yabushita Y
    Biotechnol Appl Biochem; 1988 Jun; 10(3):294-300. PubMed ID: 3395470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis and the biliary tree.
    Scott-Coombes DM; Whawell SA; Havranek EG; Thompson JN
    Gut; 1997 Jan; 40(1):92-4. PubMed ID: 9155582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro.
    Runge MS; Bode C; Matsueda GR; Haber E
    Biochemistry; 1988 Feb; 27(4):1153-7. PubMed ID: 3130094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    J Biomed Mater Res; 1981 Jul; 15(4):553-63. PubMed ID: 7024280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of urokinase.
    Shi BZ; Mao GD; Xiong ZP
    Ann N Y Acad Sci; 1988; 542():180-4. PubMed ID: 3228232
    [No Abstract]   [Full Text] [Related]  

  • 11. Immobilization of urokinase on agarose matrices.
    Kim HP; Byun SM; Yeom YI; Kim SW
    J Pharm Sci; 1983 Mar; 72(3):225-8. PubMed ID: 6221088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid.
    Chen H; Teramura Y; Iwata H
    J Control Release; 2011 Mar; 150(2):229-34. PubMed ID: 21108976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
    Abe T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis by urokinase endowed with magnetic property.
    Inada Y; Ohwada K; Yoshimoto T; Kojima S; Takahashi K; Kodera Y; Matsushima A; Saito Y
    Biochem Biophys Res Commun; 1987 Oct; 148(1):392-6. PubMed ID: 3675586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological activity of antithrombotic agents immobilized on polymer surfaces.
    Kim SW; Ebert CD; McRea JC; Briggs C; Byun SM; Kim HP
    Ann N Y Acad Sci; 1983; 416():513-24. PubMed ID: 6233925
    [No Abstract]   [Full Text] [Related]  

  • 18. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.
    Lu H; Mirshahi M; Krief P; Soria C; Soria J; Mishal Z; Bertrand O; Perrot JY; Li H; Picot C
    Biochem Biophys Res Commun; 1988 Aug; 155(1):418-22. PubMed ID: 2843185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.